Cargando…
Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein
[Formula: see text]-Lactams are the most widely used and effective antibiotics for the treatment of infectious diseases. Unfortunately, bacteria have developed several mechanisms to combat these therapeutic agents. One of the major resistance mechanisms involves the production of [Formula: see text]...
Autores principales: | Eiamphungporn, Warawan, Schaduangrat, Nalini, Malik, Aijaz Ahmad, Nantasenamat, Chanin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121496/ https://www.ncbi.nlm.nih.gov/pubmed/30061509 http://dx.doi.org/10.3390/ijms19082222 |
Ejemplares similares
-
Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors
por: Yu, Tianshi, et al.
Publicado: (2022) -
ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists
por: Schaduangrat, Nalini, et al.
Publicado: (2021) -
Towards understanding aromatase inhibitory activity via QSAR modeling
por: Shoombuatong, Watshara, et al.
Publicado: (2018) -
Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases
por: Huang, Liwen, et al.
Publicado: (2021) -
Acquired Class D β-Lactamases
por: Antunes, Nuno T., et al.
Publicado: (2014)